What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?

被引：2
|
作者：
Coates, AL [1 ]
机构：
[1] Univ Toronto, Hosp Sick Children, Div Resp Med, Dept Paediat, Toronto, ON M5G 1X8, Canada
来源：
JOURNAL OF PEDIATRICS | 2001年 / 139卷 / 06期
关键词：
D O I：
10.1067/mpd.2001.120267
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：768 / 770
页数：3
相关论文
共 50 条
  • [31] Withdrawal of dornase alfa increases ventilation inhomogeneity in children with cystic fibrosis
    Voldby, Christian
    Green, Kent
    Philipsen, Lue
    Sandvik, Rikke Mulvad
    Skov, Marianne
    Buchvald, Frederik
    Pressler, Tacjana
    Nielsen, Kim Gjerum
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (06) : 949 - 956
  • [32] Dornase Alfa for Non-Cystic Fibrosis Pediatric Pulmonary Atelectasis
    Thornby, Krisy-Ann
    Johnson, Ashley
    Axtell, Samantha
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (08) : 1040 - 1049
  • [33] Is Bronchoscopic Lung Lavage With Dornase Alfa A Therapeutic Option In Cystic Fibrosis?
    Nobuo, M. S. D. P. F.
    Pedrao, N. B.
    Athanazio, R. A.
    Rached, S. Z.
    Carvalho-Pinto, R. M.
    Cukier, A.
    Stelmach, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] FACTORS ASSOCIATED WITH INCONSISTENT DORNASE ALFA THERAPY IN PATIENTS WITH CYSTIC FIBROSIS
    Sawicki, G. S.
    VanDevanter, D.
    Schechter, M. S.
    Millar, S.
    Xu, Y.
    Pasta, D.
    Morgan, W.
    Konstan, M.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 356 - 356
  • [35] Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review
    Shah, Gopi B.
    De Keyzer, Linde
    Russell, Joy A.
    Halderman, Ashleigh
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (06) : 729 - 736
  • [36] Estimating effectiveness in an observational study: A case study of dornase alfa in cystic fibrosis
    Johnson, CA
    Butler, SM
    Konstan, MW
    Breen, TJ
    Morgan, WJ
    JOURNAL OF PEDIATRICS, 1999, 134 (06): : 734 - 739
  • [37] DEVELOPMENT OF A LONG-ACTING VERSION OF DORNASE ALFA FOR THE TREATMENT OF CYSTIC FIBROSIS
    Guichard, M-J.
    Wilms, T.
    Ucakar, B.
    Leal, T.
    Vanbever, R.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (03) : A26 - A26
  • [38] Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change
    VanDevanter, Donald R.
    Craib, Marcia L.
    Pasta, David J.
    Millar, Stefanie J.
    Morgan, Wayne J.
    Konstan, Michael W.
    PEDIATRIC PULMONOLOGY, 2018, 53 (01) : 43 - 49
  • [39] Dornase alfa is well tolerated: Data from the Epidemiologic Registry of Cystic Fibrosis
    McKenzie, S. G.
    Chowdhury, S.
    Strandvik, B.
    Hodson, M. E.
    PEDIATRIC PULMONOLOGY, 2007, 42 (10) : 928 - 937
  • [40] Dornase alfa - A practical guide to patient selection and drug use in cystic fibrosis
    Shah, PL
    Hodson, ME
    BIODRUGS, 1997, 8 (06) : 439 - 445
12345